Biomm S.A.

São Paulo Stock Exchange BIOM3.SA

Biomm S.A. Market Capitalization on January 14, 2025: USD 192.08 M

Biomm S.A. Market Capitalization is USD 192.08 M on January 14, 2025, a 51.70% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Biomm S.A. 52-week high Market Capitalization is USD 435.58 M on April 30, 2024, which is 126.77% above the current Market Capitalization.
Biomm S.A. 52-week low Market Capitalization is USD 114.89 M on February 02, 2024, which is -40.19% below the current Market Capitalization.
Biomm S.A. average Market Capitalization for the last 52 weeks is USD 228.67 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

São Paulo Stock Exchange: BIOM3.SA

Biomm S.A.

CEO	Mr. Heraldo Carvalho Marchezini
IPO Date	Jan. 11, 2000
Location	Brazil
Headquarters	Rua dos Pinheiros, 610
Employees	130
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; CONFORT CARE, a moisturizing foot cream; GLARGILIN, a glargine insulin; and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in São Paulo, Brazil.

Key trends

Past 5 years